One of the EV mRNA markers, KRT17, was confirmed to be expressed higher in those with cancer recurrence after TURBT until recurrence, while its expression gradually decreased over a time for those without cancer recurrence during the study period (Fig. 4A). Here, KRT17 is linked to cancer.